12:00 AM
Oct 26, 2009
 |  BC Week In Review  |  Company News  |  Deals

MorphoSys, Daiichi Sankyo deal

Daiichi received a non-exclusive license to use MorphoSys' HuCAL Platinum antibody library to generate antibodies against undisclosed targets for nosocomial infections. Daiichi will have exclusive...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >